EU approves SPR's nerve stimulation device for chronic shoulder pain

01/25/2013 |

SPR Therapeutics has obtained CE mark approval to market its Smartpatch Peripheral Nerve Stimulation device in Europe. The technology, which can be used for a maximum of 30 days, uses peripheral nerve stimulation to treat chronic shoulder pain. The company also is pursuing FDA approval for use of the device in treating post-amputation and post-stroke pain.

View Full Article in:

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN